Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.
Jiang J, Gui F, He Z, Li L, Li Y, Li S, Wu X, Deng Z, Sun X, Huang X, Huang W, Han S, Zhang T, Wang Z, Jiao B, Song S, Wang H, Chen L, Zhou D, Liu Q, Ren R, Zhang J, Deng X.
Jiang J, et al. Among authors: li s, li y, li l.
Cancer Res. 2017 Jan 1;77(1):175-186. doi: 10.1158/0008-5472.CAN-16-1038. Epub 2016 Oct 10.
Cancer Res. 2017.
PMID: 27758886